BedaquilinepretomaniddelamanidpancreatitislinezolidBDQDLMMHRA
…Objectives Bedaquiline (BDQ), delamanid (DLM) and pretomanid (Pa) were widely used in …
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 46 of 2459simvastatinpravastatinrisperidonearipiprazoleolanzapineatorvastatinschizophreniaSMIbipolar disorderquetiapine+1 more
…vastatin/rosuvastatin) statins; (2A) P-glycoprotein inhibitors (simvastatin/atorvastatin) versus non-inhibitors (pravastatin) in patients p…
dystoniacervical dystoniaNICEgeneralised dystoniaDeep Brain Stimulationsegmental dystoniadystonic tremorInternational Parkinson and Movement Disorders SocietyEuropean Federation of Neurological Societiesblepharospasm+3 more
…onal Parkinson and Movement Disorders Society recommend DBS for dystonia after failure of botulinum toxin (BoNT) and oral medications.Th…
98.3%
atomoxetinemethylphenidateviloxazineADHDattention deficit/hyperactivity disorderamphetamines
…tic reports. In the short term, alpha-2 agonists, amphetamines, atomoxetine, methylphenidate, and viloxazine showed medium to large effect …
attention deficit/hyperactivity disorderautismautism spectrum disorderADHDparacetamolacetaminophen
…he risk of autism spectrum disorder (referred to as autism) and attention deficit/hyperactivity disorder (ADHD) in offspring.Design Umbrella review of systematic review…
Tebentafuspmetastatic uveal melanomatebentafusp-associated
… Published online 2025 Jun 12.Tomsitz D, Ruf T, Heppt M, et al. Tebentafusp in patients with metastatic uveal melanoma: a real-life retrosp…
HX009HX111solid tumorsNK/T-cell lymphomahistiocytic lymphomaATLOX40-mAbsautoimmune diseases
…47 Bi-specific antibody. Sci Rep. 2024;14(1):28201.Ke H, et al. HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent an…
CRCMD Anderson Cancer Centerhepatocellular carcinomagastroesophageal cancerHCCKRAS inhibitorsgastroesophageal carcinomacholangiocarcinomaPDAC
…allele. The top mutated genes were TP53 (71%) and APC (63%) for CRC, TP53 (76%) and CDKN2A (28%) for PDAC, GNAS (34%) and TP53 (34%…
PDS01ADCadvanced solid tumorsNHS-muIL12metastatic solid tumorsNHS-IL12entinostat
… on peripheral T cell stemness in mice and humans. We show that PDS01ADC treatment in patients with advanced solid tumors boosts periphe…
DocetaxelNSCLCatezolizumabnon-small cell lung cancerhSTC810
…k sac of zebrafish embryos, followed by systemic treatment with Docetaxel. Tumor burden was quantified using fluorescence microscopy, and…
NM32-2668NM32-2668-101esophageal cancerJohns Hopkins University School of MedicineMoffitt Cancer CenterUniversity of Wisconsin Carbone Cancer CentermesotheliomaAlbert Einstein Cancer CenterThe University of Texas MD Anderson Cancer CenterGabrail Cancer Center+4 more
…dynamics, immunogenicity, and preliminary antitumor activity of NM32-2668 monotherapy administered every two weeks to patients with ROR1-…
MitazalimabmFOLFIRINOX
…and 89.5% OS) compared with 450 µg/kg (38.7% PFS and 69.4% OS). Mitazalimab in combination with mFOLFIRINOX demonstrated a manageable safet…